{"entity":{"id":"nct07114315","kind":"trial","name":"A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer","aka":[],"tldr":"A phase 2 trial of AK112 in pancreatic ductal adenocarcinoma, run by Akeso, now recruiting.","summary":"A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer is a phase 2 interventional study registered as NCT07114315 by Akeso, with 160 participants planned, started 2025-09-19 and due to reach its primary completion in 2027-08. Interventions recorded: AK112 and AK130.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07114315","url":"https://clinicaltrials.gov/study/NCT07114315"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["pancreatic"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["akeso"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT07114315","phase":"2","setting":"A Phase II Clinical Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer","sponsor":"Akeso","enrolled":160,"outcomes":[]},"route":"/trials/nct07114315/","neighbours":{"cancer":[{"id":"pancreatic","kind":"cancer","name":"Pancreatic ductal adenocarcinoma","route":"/cancers/pancreatic/"}],"company":[{"id":"akeso","kind":"company","name":"Akeso","route":"/companies/akeso/"}]}}